Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (781-790 of 1,398) with videos related to

Pageof 140
Sort By:
Neuro-Oncology|August 31, 2022
In vivo functional characterization of EGFR variants identifies novel drivers of glioblastomaKwanha Yu, Kathleen Kong, Brittney Lozzi, et al.
The Journal of Biological Chemistry|September 15, 1995
Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chainM A Goldsmith, S Y Lai, W Xu, et al.
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptorM R Fung, R M Scearce, J A Hoffman, et al.
Cancer Research|July 17, 2001
Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosisK Mujoo, V Haridas, J J Hoffmann, et al.
Biochimica Et Biophysica Acta|June 19, 2002
Lysophosphatidic acid is a bioactive mediator in ovarian cancerXianjun Fang, Michel Schummer, Muling Mao, et al.
Nature Communications|February 14, 2019
Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancerXinran Li, Victor C Y Mak, Yuan Zhou, et al.
Cytotherapy|August 13, 2002
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cellsJ Burgess, B Mills, M Griffith, et al.
Oncogene|April 12, 2018
BRD4 facilitates replication stress-induced DNA damage responseJingwen Zhang, Austin M Dulak, Maureen M Hattersley, et al.
Cancer Research|February 3, 2006
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AktKathryn E O'Reilly, Fredi Rojo, Qing-Bai She, et al.
Pageof 140

Showing results (781-790 of 1,398) with videos related to

Sort By:
Pageof 140
Neuro-Oncology|August 31, 2022
In vivo functional characterization of EGFR variants identifies novel drivers of glioblastomaKwanha Yu, Kathleen Kong, Brittney Lozzi, et al.
The Journal of Biological Chemistry|September 15, 1995
Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chainM A Goldsmith, S Y Lai, W Xu, et al.
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptorM R Fung, R M Scearce, J A Hoffman, et al.
Cancer Research|July 17, 2001
Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosisK Mujoo, V Haridas, J J Hoffmann, et al.
Biochimica Et Biophysica Acta|June 19, 2002
Lysophosphatidic acid is a bioactive mediator in ovarian cancerXianjun Fang, Michel Schummer, Muling Mao, et al.
Nature Communications|February 14, 2019
Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancerXinran Li, Victor C Y Mak, Yuan Zhou, et al.
Cytotherapy|August 13, 2002
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cellsJ Burgess, B Mills, M Griffith, et al.
Oncogene|April 12, 2018
BRD4 facilitates replication stress-induced DNA damage responseJingwen Zhang, Austin M Dulak, Maureen M Hattersley, et al.
Cancer Research|February 3, 2006
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AktKathryn E O'Reilly, Fredi Rojo, Qing-Bai She, et al.
Pageof 140